Using Mutational Signatures To Tailor New Treatments

Thomas Helleday, Phd, Helleday Laboratory, Discusses Using Mutational Signatures To Tailor New Treatments. At ESMO Oncology Conference - Munich, Germany On October 19, 2018. Author: Cancer-News Added: 10/29/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts